AN ACT relating to investment in youth vaping prevention.
Summary
HB187 creates a new trust and agency account in the State Treasury called the vaping settlement trust fund, administered by the Kentucky Office of the Attorney General. The fund would receive proceeds the Commonwealth obtains on or after July 1, 2025 from any settlement, judgment, or bankruptcy proceeding against Juul Labs Inc., after excluding litigation or investigative costs awarded to the Attorney General’s office.
Money in the fund must be used only by the Department for Public Health’s Tobacco Prevention and Cessation Program for youth vaping prevention and cessation efforts. The bill also requires the money to be distributed at least annually and prevents unspent balances from lapsing at the end of a fiscal year, allowing them to carry forward.
Impact
The bill would add a new section to KRS Chapter 15 and create a dedicated state fund for Juul-related recovery dollars. It directs those revenues away from the general fund and into a restricted account for public health programming, specifically youth vaping prevention and cessation. The measure also overrides the normal lapse rule in KRS 45.229 for this fund, ensuring balances remain available across fiscal years.
Sentiment
Based on the bill text and the absence of recorded committee debate or votes in the provided materials, the bill appears to be framed as a targeted public health measure with a straightforward purpose. Its focus on youth vaping prevention and use of settlement proceeds suggests generally favorable policy intent, with no documented opposition or amendment activity in the available record. The lack of transcripts or vote history means there is no evidence here of significant controversy in committee or on the floor.
Contention
The main potential point of contention is the earmarking of settlement proceeds: the bill restricts use of Juul-related funds to a specific program rather than allowing broader budget flexibility. Another possible issue is the administrative control of the fund by the Attorney General’s office versus the public health agency that spends the money, though the bill clearly assigns programmatic use to the Department for Public Health. No explicit objections, competing proposals, or recorded disputes are included in the provided context.